During REM sleep, the body enters a state of paralysis. This can pose a danger for patients with weakened diaphragms due to ...

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant ...

Treatment with an experimental drug has shown significant improvements in young patients with a rare form of Amyotrophic ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

Asked by Sen. Lisa Murkowski of Alaska how cuts in research funding could affect the search for treatments for specific ...

Mitochondria turn the food we eat into the energy our cells can use. But when stress hijacks the process they use to maintain ...

A recent court evaluation of the league's billion-dollar compensation program shows that it has gotten more efficient, but ...

BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis: New York Wednesday, May 21, 2025, 18:00 Hrs [IST] BrainStorm Cell Therapeutics ...

Peptidomimetics are synthetic analogs that retain the essential structure and function of peptides but with chemical ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive degeneration of motor neurons in the spinal cord and brain.